Symbols / DBV $25.41 -0.63%
DBV Chart
About
The Advisor invests in futures contracts in an attempt to track its index (“index contracts”). The index is designed to reflect the return from investing on a 2:1 leveraged basis in long currency futures positions for certain currencies associated with relatively high yielding interest rates and in short currency futures positions for certain currencies associated with relatively low yielding interest rates.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | 75.00% |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | 26.46 | 52W Low | 24.25 |
| Beta | — | Avg Volume | 0.00 | Volume | 1.40K |
| Target Price | — | Recom | — | Prev Close | $25.57 |
| Price | $25.41 | Change | -0.63% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest DBV news- DBV Technologies (NASDAQ:DBVT) Shares Gap Down - What's Next? - MarketBeat Wed, 11 Mar 2026 16
- DBV Technologies (ENXTPA:DBV) Valuation After Positive Phase 3 Peanut Patch Results - simplywall.st ue, 10 Mar 2026 14
- Is DBV Technologies S.A. Depositary Receipt stock a top pick in earnings season - Quarterly Trade Review & Growth-Oriented Investment Plans - Naître et grandir Sat, 07 Mar 2026 12
- DBV Technologies stock surges on new peanut patch trial data - Investing.com Mon, 02 Mar 2026 08
- Assessing DBV Technologies (ENXTPA:DBV) Valuation After Mixed Recent Share Performance - Yahoo Finance Mon, 02 Mar 2026 08
- DBV's peanut allergy patch finally finds clinical success, sending shares soaring - FirstWord Pharma ue, 16 Dec 2025 08
- Did This Biotech Just Solve Peanut Allergies? Shares Catapult. - Investor's Business Daily Wed, 17 Dec 2025 08
- Will DBV Technologies S.A. Depositary Receipt stock recover faster than peers - Portfolio Growth Summary & Accurate Intraday Trade Tips - Naître et grandir Sat, 07 Mar 2026 15
- Is DBV Technologies (DBVT) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance Fri, 31 Oct 2025 07
- DBV Technologies stock soars after positive Phase 3 trial results - Investing.com ue, 16 Dec 2025 08
- DBV Technologies (NASDAQ:DBVT) Shares Up 10% - Time to Buy? - MarketBeat Mon, 02 Mar 2026 08
- Will Positive Phase 3 VITESSE Peanut Patch Data Change DBV Technologies' (ENXTPA:DBV) Narrative? - simplywall.st Mon, 09 Mar 2026 13
- Citizens reiterates DBV Technologies stock rating on Viaskin Peanut potential - Investing.com Nigeria ue, 03 Mar 2026 11
- DBV Technologies to Participate in Upcoming March Investor Conferences - Yahoo Finance Wed, 04 Mar 2026 21
- Is DBV Technologies (ENXTPA:DBV) Offering Opportunity After 364% One-Year Share Price Surge - simplywall.st Sat, 07 Mar 2026 14
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for DBV
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|